The Enterprise Value as of December 2024 (TTM) for Purple Biotech Ltd. (PPBT) is 4.44M

According to Purple Biotech Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.44M. This represents a change of -5.31% compared to the average of 4.69M of the last 4 quarters.

Purple Biotech Ltd. (PPBT) Historical Enterprise Value (quarterly & annually)

How has PPBT Enterprise Value performed in the past?

The mean historical Enterprise Value of Purple Biotech Ltd. over the last ten years is 14.63M. The current 4.44M Enterprise Value has changed 2.94% with respect to the historical average. Over the past ten years (40 quarters), PPBT's Enterprise Value was at its highest in in the June 2021 quarter at 75.42M. The Enterprise Value was at its lowest in in the March 2020 quarter at -41370378.04.

Purple Biotech Ltd. (PPBT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Purple Biotech Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Purple Biotech Ltd. (PPBT) Average Enterprise Value

How has PPBT Enterprise Value performed in the past?

The current Enterprise Value of Purple Biotech Ltd. (PPBT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Purple Biotech Ltd. (PPBT) Enterprise Value vs. Peers

How is PPBT’s Enterprise Value compared to its peers?

Purple Biotech Ltd.’s Enterprise Value is less than Pluri Inc. (52.05M), less than BioLineRx Ltd. (44.85M), less than Aridis Pharmaceuticals, Inc. (4.81M), less than Enlivex Therapeutics Ltd. (25.04M), less than Anebulo Pharmaceuticals, Inc. (40.61M), less than PMV Pharmaceuticals, Inc. (40.53M), less than Miromatrix Medical Inc. (90.06M), less than ZIVO Bioscience, Inc. (78.24M), less than Bionomics Limited (1.25B), greater than Bio-Path Holdings, Inc. (3.94M), less than Endonovo Therapeutics, Inc. (7.14M), less than Cingulate Inc. (5.81M), less than Soleno Therapeutics, Inc. (1.88B), less than Cingulate Inc. (0), less than SAB Biotherapeutics, Inc. (5.81M), less than Cadrenal Therapeutics, Inc. Common Stock (33.19M), less than Monopar Therapeutics Inc. (20.14M), less than null (110.36M),

Build a custom stock screener for Purple Biotech Ltd. (PPBT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Purple Biotech Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Purple Biotech Ltd. (PPBT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Purple Biotech Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.